Cargando…
Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States
Prostate cancer represents the most frequent tumor in men, accounting for the 21% of all diagnosed tumors, with 191,930 new cases and 33,330 deaths estimated in 2020. Advanced prostate cancer represents a heterogeneous disease, ranging from hormone naive or hormone sensitive to castration resistant....
Autores principales: | Santoni, Matteo, Cimadamore, Alessia, Massari, Francesco, Sorgentoni, Giulia, Cheng, Liang, Lopez-Beltran, Antonio, Battelli, Nicola, Montironi, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039584/ https://www.ncbi.nlm.nih.gov/pubmed/33850790 http://dx.doi.org/10.21037/tau-20-1439 |
Ejemplares similares
-
Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
por: Montironi, Rodolfo, et al.
Publicado: (2021) -
Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021) -
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?—a narrative review
por: Rizzo, Alessandro, et al.
Publicado: (2021) -
Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
por: Cimadamore, Alessia, et al.
Publicado: (2021) -
Digital diagnostics and artificial intelligence in prostate cancer treatment in 5 years from now
por: Cimadamore, Alessia, et al.
Publicado: (2021)